Lv6
2320 积分 2025-04-09 加入
PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity
14天前
已完结
Navigating gene expression using microarrays — a technology review
22天前
已完结
Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes
26天前
已完结
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy
1个月前
已完结
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy
1个月前
已完结
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
1个月前
已关闭
PTPN2: Advances and perspectives in cancer treatment potential and inhibitor research
1个月前
已完结
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents
1个月前
已完结
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
1个月前
已完结
Discovery of a selective TC-PTP degrader for cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
